{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:33:15Z","timestamp":1759937595743},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T00:00:00Z","timestamp":1360886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00296-013-2693-4","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T12:35:01Z","timestamp":1360845301000},"page":"857-860","source":"Crossref","is-referenced-by-count":18,"title":["Efficacy of adalimumab therapy for life-threatening pulmonary vasculitis in Beh\u00e7et\u2019s disease"],"prefix":"10.1007","volume":"34","author":[{"given":"Suhail","family":"Aamar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagit","family":"Peleg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Leibowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tova","family":"Chajek-Shaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurith","family":"Hiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel N.","family":"Heyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,15]]},"reference":[{"key":"2693_CR1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10067-005-0166-1","volume":"26","author":"D Planer","year":"2007","unstructured":"Planer D, Leibowitz D, Elitzur Y, Korach A, Hiller N, Chajek-Shaul T (2007) Chronicle of a death foretold: a case of catastrophic vascular Behcet\u2019s disease. Clin Rheumatol 26:457\u2013459","journal-title":"Clin Rheumatol"},{"issue":"Suppl 2","key":"2693_CR2","doi-asserted-by":"crossref","first-page":"i51","DOI":"10.1136\/ard.61.suppl_2.ii51","volume":"61","author":"PP Sfikakis","year":"2002","unstructured":"Sfikakis PP (2002) Behcet\u2019s disease: a new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 61(Suppl 2):i51\u2013i53","journal-title":"Ann Rheum Dis"},{"key":"2693_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00296-003-0400-6","volume":"25","author":"N Duzgun","year":"2005","unstructured":"Duzgun N, Ayaslioglu E, Tutkak H, Aydintug OT (2005) Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behcet\u2019s disease. Rheumatol Int 25:1\u20135","journal-title":"Rheumatol Int"},{"key":"2693_CR4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.euje.2006.07.013","volume":"8","author":"D Leibowitz","year":"2007","unstructured":"Leibowitz D, Planer D, Chajek-Shaul T (2007) Echocardiographic manifestations of Adamantiades-Behcet\u2019s disease. Eur J Echocardiogr 8:457\u2013462","journal-title":"Eur J Echocardiogr"},{"key":"2693_CR5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cyto.2003.09.003","volume":"24","author":"M Misumi","year":"2003","unstructured":"Misumi M, Hagiwara E, Takeno M, Takeda Y, Inoue Y, Tsuji T, Ueda A, Nakamura S, Ohno S, Ishigatsubo Y (2003) Cytokine production profile in patients with Behcet\u2019s disease treated with infliximab. Cytokine 24:210\u2013218","journal-title":"Cytokine"},{"key":"2693_CR6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/art.10815","volume":"48","author":"T Ahmad","year":"2003","unstructured":"Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K, Armuzzi A, Crawshaw J, Fortune F, Walton R, Stanford MR, Welsh KI, Marshall SE, Jewell DP (2003) Mapping the HLA association in Behcet\u2019s disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum 48:807\u2013813","journal-title":"Arthritis Rheum"},{"key":"2693_CR7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.humimm.2006.12.006","volume":"68","author":"M Kamoun","year":"2007","unstructured":"Kamoun M, Chelbi H, Houman MH, Lacheb J, Hamzaoui K (2007) Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet\u2019s disease. Hum Immunol 68:201\u2013205","journal-title":"Hum Immunol"},{"key":"2693_CR8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1167\/iovs.10-5916","volume":"52","author":"S Sugita","year":"2011","unstructured":"Sugita S, Yamada Y, Kaneko S, Horie S, Mochizuki M (2011) Induction of regulatory T cells by infliximab in Behcet\u2019s disease. Invest Ophthalmol Vis Sci 52:476\u2013484","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2693_CR9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10067-009-1272-2","volume":"29","author":"SW Lee","year":"2010","unstructured":"Lee SW, Lee SY, Kim KN, Jung JK, Chung WT (2010) Adalimumab treatment for life threatening pulmonary artery aneurysm in Behcet disease: a case report. Clin Rheumatol 29:91\u201393","journal-title":"Clin Rheumatol"},{"key":"2693_CR10","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1136\/ard.2005.045195","volume":"65","author":"K Baki","year":"2006","unstructured":"Baki K, Villiger PM, Jenni D, Meyer T, Beer JH (2006) Behcet\u2019s disease with life-threatening haemoptoe and pulmonary aneurysms: complete remission after infliximab treatment. Ann Rheum Dis 65:1531\u20131532","journal-title":"Ann Rheum Dis"},{"key":"2693_CR11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/acr.21557","volume":"64","author":"S Adler","year":"2012","unstructured":"Adler S, Baumgartner I, Villiger PM (2012) Behcet \u2018s disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis. Arthritis Care Res 64:607\u2013611","journal-title":"A retrospective analysis. Arthritis Care Res"},{"issue":"Suppl 67","key":"2693_CR12","first-page":"S94","volume":"29","author":"C Tolosa-Vilella","year":"2011","unstructured":"Tolosa-Vilella C, Capela CA, Monteagudo-Jim\u00e9nez M, Mar\u00ed\u2013Alfonso B (2011) Infliximab for life-threatening pulmonary artery aneurysms in Behcet \u2018s disease a case report. Clin Exp Rheumatol 29(Suppl 67):S94\u2013S95","journal-title":"Clin Exp Rheumatol"},{"key":"2693_CR13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/PAS.0b013e31814b23da","volume":"32","author":"I Lee","year":"2008","unstructured":"Lee I, Park S, Hwang I, Kim MJ, Nah SS, Yoo B, Song JK (2008) Cardiac Behcet disease presenting as aortic valvulitis\/aortitis or right heart inflammatory mass: a clinicopathologic study of 12 cases. Am J Surg Pathol 32:390\u2013398","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 67","key":"2693_CR14","first-page":"S54","volume":"29","author":"I Olivieri","year":"2011","unstructured":"Olivieri I, Leccese P, D\u2019Angelo S, Padula A, Nigro A, Palazzi C, Coniglio G, Latanza L (2011) Efficacy of adalimumab in patients with Beh\u00e7et\u2019s disease unsuccessfully treated with infliximab. Clin Exp Rheumatol 29(Suppl 67):S54\u2013S57","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 67","key":"2693_CR15","first-page":"S93","volume":"29","author":"P Leccese","year":"2011","unstructured":"Leccese P, Latanza L, D\u2019Angelo S, Padula A, Olivieri I (2011) Efficacy of switching to adalimumab in a patient with refractory uveitis of Beh\u00e7et\u2019s disease to infliximab. Clin Exp Rheumatol 29(Suppl 67):S93","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 60","key":"2693_CR16","first-page":"S102","volume":"28","author":"P Leccese","year":"2010","unstructured":"Leccese P, D\u2019Angelo S, Angela P, Coniglio G, Olivieri I (2010) Switching to adalimumab is effective in a case of neuro-Behcet\u2019s disease refractory to infliximab. Clin Exp Rheumatol 28(Suppl 60):S102","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 60","key":"2693_CR17","first-page":"S94","volume":"28","author":"F Atzeni","year":"2010","unstructured":"Atzeni F, Leccese P, D\u2019Angelo S, Sarzi-Puttini P, Olivieri I (2010) Successful treatment of leg ulcers in Beh\u00e7et\u2019s disease using adalimumab plus methotrexate after the failure of infliximab. Clin Exp Rheumatol 28(Suppl 60):S94","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 53","key":"2693_CR18","first-page":"S112","volume":"27","author":"I Olivieri","year":"2009","unstructured":"Olivieri I, D\u2019Angelo S, Padula A, Leccese P, Mennillo GA (2009) Successful treatment of recalcitrant genital ulcers of Behcet\u2019s disease with adalimumab after failure of infliximab and etanercept. Clin Exp Rheumatol 27(Suppl 53):S112","journal-title":"Clin Exp Rheumatol"},{"key":"2693_CR19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10792-011-9430-3","volume":"31","author":"P Neri","year":"2011","unstructured":"Neri P, Zucchi M, Allegri P, Lettieri M, Mariotti C, Giovannini A (2011) Adalimumab (Humira\u2122): a promising monoclonal anti-tumor necrosis factor alpha in ophthalmology. Int Ophthalmol 31:165\u2013173","journal-title":"Int Ophthalmol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2693-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-013-2693-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2693-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:21:44Z","timestamp":1559042504000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-013-2693-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,15]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["2693"],"URL":"https:\/\/doi.org\/10.1007\/s00296-013-2693-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,15]]}}}